Despite these limitations, this study provided a systematic presentation of the clinical characteristics of PD-1/PD-L1 inhibitor–related PNS, offering important insights for identifying high-risk populations and developing intervention strategies. The gene discussed is PDCD1; the disease is paraneoplastic neurologic syndrome.